RegCell Co.
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $63M
Investors
- 19
About RegCell Co.
Based in Japan, RegCell, Inc. focuses on innovative immune system control technologies, specifically the development and application of regulatory T cells (Tregs) for therapeutic solutions in various medical conditions., founded in 2016, specializes in immune system control technologies., Ltd. RegCell, Inc. specializes in innovative immune system control technologies through the development and application of regulatory T cells (Tregs). Their offerings focus on advanced therapeutic solutions aimed at modulating immune responses in conditions such as autoimmune diseases, cancer, and transplant rejection. The company targets healthcare providers, research institutions, and pharmaceutical companies across Japan, the United States, and Europe, aiming to improve patient outcomes in immunological scenarios. RegCell, Inc. generates revenue through direct sales and partnerships with healthcare organizations and research institutions that utilize their Treg-based therapies. Revenue is derived from agreements with hospitals and clinics, where RegCell's products are integrated into treatment regimens or clinical trials. The company may also engage in collaborations with pharmaceutical firms for the co-development of specialized therapies, aligning with premium pricing strategies typically seen in the biopharmaceutical sector.
Who invested in RegCell Co.
19 investors across 4 rounds
See all investors in RegCell Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RegCell Co.
Who invested in RegCell Co.?
RegCell Co. has 19 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RegCell Co. raised?
RegCell Co. has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did RegCell Co. last raise money?
RegCell Co.'s most recent round on record is a Series A, in Sep 2026.
What does RegCell Co. do?
RegCell Co. is a biotechnology company.
Where is RegCell Co. headquartered?
RegCell Co. is headquartered in Emeryville, US.
Which VCs invest in companies like RegCell Co.?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RegCell Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RegCell Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.